| Contrast-enhanced MR Imaging as a Breast Cancer Screening in Women at Intermediate Risk (NCT02210546) | Prof. Paolo Bruzzi | 2013-05-01 |
| Interest of Self-compression Technique on Tolerance of Mammography (NCT02866591) | Institut de Cancérologie de Lorraine | 2013-05-01 |
| Identification and Semi -Quantification of ER/PR Proteins Expression (NCT02654431) | Applied Spectral Imaging Ltd. | 2013-05-01 |
| Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors (NCT01803503) | National University Hospital, Singapore | 2013-05-01 |
| Semi-Quantification of Her2/Neu Protein Expression in Formalin Fixed, Paraffin-Embedded Normal and Neoplastic Tissue (NCT02654444) | Applied Spectral Imaging Ltd. | 2013-05-01 |
| FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer Patients (NCT01864083) | Memorial Sloan Kettering Cancer Center | 2013-05-01 |
| Paclitaxol Every 2 Week Versus Paclitaxol Every 1 Week in the Adjuvant Treatment of Breast Cancer (NCT01848197) | Taizhou Hospital | 2013-05-01 |
| Eribulin in HER2 Negative Metastatic BrCa (NCT01827787) | Dana-Farber Cancer Institute | 2013-05-01 |
| PET/CT or PET/MRI in Measuring Tumors in Patients Undergoing Clinical Imaging or With Newly Diagnosed Breast Cancer (NCT01892540) | Case Comprehensive Cancer Center | 2013-05-01 |
| Testing Spectrosense EVA System for Detection of Breast Cancer by Analyzing Volatile Organic Compounds (VOCs) in Exhaled Air (NCT01849328) | Rauscher, Gregory E., M.D. PA | 2013-05-01 |
| Anti-Mullerian Hormone (AMH) as Marker of Ovarian Reserve (NCT02113553) | Armando Santoro, MD | 2013-05-01 |
| A Study Comparing ex Vivo MRI Versus Radiography of Breast Specimens (NCT01869335) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2013-05-01 |
| Phase II Study of Docetaxel +/- Nintedanib in Breast Cancer (NCT01658462) | Centre Oscar Lambret | 2013-05-01 |
| Nueva Vida Intervention for Latina Breast Cancer Survivors and Caregivers (NCT02222337) | Georgetown University | 2013-05-01 |
| T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial) (NCT01853748) | Dana-Farber Cancer Institute | 2013-05-01 |
| Efficacy and Safety Study of ABP 980 Compared With Trastuzumab in Women With HER2-positive Early Breast Cancer (NCT01901146) | Amgen | 2013-04-29 |
| Investigation of Genomic Alteration in Patients With Luminal A or Luminal B Subtypes (NCT04403984) | Hellenic Cooperative Oncology Group | 2013-04-24 |
| Investigation of Gene Mutations in Patients With Triple-negative and Patients With HER2+ Breast Cancer Adenocarcinoma (NCT04365790) | Hellenic Cooperative Oncology Group | 2013-04-18 |
| Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer (NCT01793948) | Anna Maria Storniolo | 2013-04-16 |
| Young Breast Cancer Cohort Study (NCT03131089) | Samsung Medical Center | 2013-04-11 |
| A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE) (NCT01772472) | Hoffmann-La Roche | 2013-04-03 |
| Neoadjuvant Chemotherapy With Nab-paclitaxel in Women With HER2-negative High-risk Breast Cancer (NCT01822314) | Fondazione Michelangelo | 2013-04-01 |
| Using Technology to Improve Physical Activity Levels Among Postmenopausal Women (The Active & Aware Study) (NCT01837147) | University of California, San Diego | 2013-04-01 |
| Accountability for Cancer Care Through Undoing Racism and Equity (NCT01954641) | University of North Carolina, Chapel Hill | 2013-04-01 |
| PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy to Prevent Neutropenia (NCT02805205) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2013-04-01 |
| PET Study of Breast Cancer Patients Using [68Ga]ABY-025 (NCT01858116) | Biomedical Radiation Sciences | 2013-04-01 |
| Long Term Results of the Canadian Breast IMRT Study (NCT01803139) | Sunnybrook Health Sciences Centre | 2013-04-01 |
| Efficacy Study of Herceptin to Treat HER2-negative CTC Breast Cancer (NCT01548677) | European Organisation for Research and Treatment of Cancer - EORTC | 2013-04-01 |
| Risk Factors for Medium-term Adverse Outcomes and Predictive Modeling for Breast Cancer Patients (NCT02439554) | Hospital Galdakao-Usansolo | 2013-04-01 |
| Second Echelon Node Study With Methylene Blue (NCT01823172) | Mayo Clinic | 2013-04-01 |
| Rx for Better Breast Health (NCT02279303) | The University of Texas Health Science Center at San Antonio | 2013-04-01 |
| Verbal and Written Instruction Versus Verbal and Written Plus Simulation in Patients With Breast Cancer and Their Caregivers (NCT01829984) | Memorial Sloan Kettering Cancer Center | 2013-04-01 |
| Clinical Trial of Quantitative Detection Kit for Hsp90α in Breast Cancer (NCT02324101) | Protgen Ltd | 2013-04-01 |
| Anti-Tumor Immunity Induced by Cryoablation of Invasive Breast Cancers (NCT01856036) | Saint John's Cancer Institute | 2013-04-01 |
| IST Neoadjuvant Abraxane in Newly Diagnosed Breast Cancer (NCT01830244) | Barwon Health | 2013-04-01 |
| Carvedilol Effect in Preventing Chemotherapy - Induced Cardiotoxicity (NCT01724450) | University of Sao Paulo | 2013-04-01 |
| Comparison of Preoperative ABUS and MRI in Newly Diagnosed Breast Cancer Patients (NCT02488187) | University of Kansas Medical Center | 2013-04-01 |
| PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy (NCT02805153) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2013-04-01 |
| Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors (NCT01803282) | Gilead Sciences | 2013-03-29 |
| Study to Assess Perfusion and Patient Satisfaction in Nipple-Areola Mastectomy With Immediate Reconstruction (NCT01969448) | Washington University School of Medicine | 2013-03-28 |
| Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing (NCT01730118) | National Cancer Institute (NCI) | 2013-03-04 |
| Evaluation of the Efficacy of Hippocampal Avoidance on the Cognitive Toxicity of Whole-Brain Radiation Therapy After Surgical Resection of Single Brain Metastasis of Breast Cancer (NCT01942980) | Institut Paoli-Calmettes | 2013-03-01 |
| Pilot 3D Mammography Reader Study to Assess Breast Cancer Detection in 3D Versus 2D Digital Mammography (NCT01928992) | Fujifilm Medical Systems USA, Inc. | 2013-03-01 |
| Phase 2 Study of the Monoclonal Antibody MGAH22 (Margetuximab) in Patients With Relapsed or Refractory Advanced Breast Cancer (NCT01828021) | MacroGenics | 2013-03-01 |
| Breast Cancer Biomarker Sample Collection for the dtectDx Assay Verification (NCT01839045) | Provista Diagnostics, Inc | 2013-03-01 |
| Outpatient Clinic for Late Outcome for Breast Carcinoma in MAASTRO Clinic. (NCT01978756) | Maastricht Radiation Oncology | 2013-03-01 |
| Automated Breast Radiation Therapy Using an MR-Guided Process (NCT01999062) | University Health Network, Toronto | 2013-03-01 |
| Adapted Physical Activity Effect on Aerobic Function and Fatigue at Home in Patients With Breast Cancer Treated in Adjuvant or Neoadjuvant Phase (NCT01795612) | University Hospital, Limoges | 2013-03-01 |
| A Phase III Trial of Carboplatin as Adjuvant Chemotherapy in Triple Negative Breast Cancer (NCT01752686) | Severance Hospital | 2013-03-01 |
| Halaven Post-Marketing Surveillance (PMS) (NCT02441764) | Eisai Korea Inc. | 2013-03-01 |
| Assessment of Ability of Breath Hold for Left-sided Breast Cancer Radiation Therapy to Reduce Side Effects to Heart (NCT01849614) | UNC Lineberger Comprehensive Cancer Center | 2013-03-01 |
| Dietary Energy Restriction and Omega-3 Fatty Acids on Mammary Tissue (NCT01784042) | Milton S. Hershey Medical Center | 2013-03-01 |
| Pecs II Block and PaB Could be an Alternative in Breast Surgery (NCT02865265) | Emiliano Petrucci | 2013-03-01 |
| Functional Anatomical Examination of Axillary Sentinel Lymph Node Drainage in the Axillary Subregions in Early Breast Cancer (NCT01804309) | National Institute of Oncology, Hungary | 2013-03-01 |
| Effect of a Diet and Physical Activity Intervention in Breast Cancer Survivors (NCT02067481) | Institut Català d'Oncologia | 2013-03-01 |
| A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer. (NCT01783444) | Novartis Pharmaceuticals | 2013-02-26 |
| Step by Step After Cancer (NCT02785861) | Centre Hospitalier Universitaire, Amiens | 2013-02-18 |
| A Phase I Dose Escalation Study of Eribulin Plus Weekly Carboplatin for Metastatic Breast Patients (NCT01795586) | H. Lee Moffitt Cancer Center and Research Institute | 2013-02-06 |
| A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Participants With Locally Recurrent or Metastatic Breast Cancer (NCT01740336) | Genentech, Inc. | 2013-02-06 |
| QOL Assessment in Breast Cancer Patients With Radiation-Induced Telangiectasias Treated With the Pulsed Dye Laser (NCT01803516) | Memorial Sloan Kettering Cancer Center | 2013-02-01 |
| Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy (NCT01697345) | Creighton University | 2013-02-01 |
| Acupuncture to Prevent Chemotherapy Dose Reduction Due to Chemotherapy-induced Peripheral Neuropathy in Breast and Colorectal Cancer Patients (GCC1232) (NCT01881932) | University of Maryland, Baltimore | 2013-02-01 |
| Psychosocial Support to Facilitate the Return to Employment of Women With Breast Cancer (NCT01780064) | Centre Oscar Lambret | 2013-02-01 |
| A Randomized Trial of Letters From Family Physicians to Encourage Screening Mammography in Overdue Women (NCT02660788) | British Columbia Cancer Agency | 2013-02-01 |
| Vaginal DHEA for Women After Breast Cancer (NCT01724242) | Hadassah Medical Organization | 2013-02-01 |
| Phase 1/2 Study of ThermoDox With Approved Hyperthermia in Treatment of Breast Cancer Recurrence at the Chest Wall (NCT00826085) | Imunon | 2013-02-01 |
| Effect of the LIVESTRONG at the YMCA Exercise Program on Cancer Related Outcomes in Cancer Survivors (NCT02112149) | Yale University | 2013-02-01 |
| Proton Radiation for Stage II/III Breast Cancer (NCT01758445) | Proton Collaborative Group | 2013-02-01 |
| Cabozantinib for Metastatic Triple Negative BrCa (NCT01738438) | Dana-Farber Cancer Institute | 2013-02-01 |
| Pilot Study for a Prospective Surveillance Program for Rehabilitation Following Surgery for Breast Cancer (NCT02754427) | University of British Columbia | 2013-02-01 |
| Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma (NCT01788839) | Memorial Sloan Kettering Cancer Center | 2013-02-01 |
| Pilot Study to Evaluate Safety & Biological Effects of Orally Administered Reparixin in Early Breast Cancer (NCT01861054) | Dompé Farmaceutici S.p.A | 2013-02-01 |
| Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood Samples (NCT01792882) | Global BioClinical | 2013-02-01 |
| Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer (NCT01766297) | Proton Collaborative Group | 2013-02-01 |
| Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care (NCT01468675) | Brigham and Women's Hospital | 2013-02-01 |
| Technology and Navigation to Improve Survivorship Care (NCT01663870) | M.D. Anderson Cancer Center | 2013-02-01 |
| EFficacy and Impact on Function of Two Different Doses of Nab-paclitaxEl in Elderly With advanCed breasT Cancer (NCT02783222) | Fondazione Sandro Pitigliani | 2013-01-30 |
| Controlled Low Calorie Diet in Reducing Side Effects and Increasing Response to Chemotherapy in Patients With Breast or Prostate Cancer (NCT01802346) | University of Southern California | 2013-01-29 |
| Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim (NCT01752907) | Amgen | 2013-01-17 |
| Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy (NCT01777802) | Mayo Clinic | 2013-01-02 |
| Single vs. Double Drain in Modified Radical Mastectomy (NCT02411617) | Memon Medical Institute | 2013-01-01 |
| ICG Distribution Using NIF Imaging After IV Injection of ICG in Benign and Malignant Breast Cancer Tissue. (NCT01993576) | Jules Bordet Institute | 2013-01-01 |
| A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep) (NCT02597868) | Zhejiang Cancer Hospital | 2013-01-01 |
| Neoadjuvant Tamoxifen in Locally Advanced Breast Cancer in a Low/Middle Income Country (NCT02806544) | Vanderbilt University | 2013-01-01 |
| Tailored Screening for Breast Cancer in Premenopausal Women (NCT02619123) | Cancer Prevention and Research Institute, Italy | 2013-01-01 |
| The Safety and Effects of Gefitinib in Triple-negative,EGFR Positive Metastatic Breast Cancer (NCT01732276) | Jiangmen Central Hospital | 2013-01-01 |
| Metronomic Chemotherapy of Capecitabine After Standard Adjuvant Chemotherapy in Operable Triple Negative Breast Cancer (NCT02012634) | Xijing Hospital | 2013-01-01 |
| C11 AMT Positron Emission Tomography (PET) Imaging in Patients With Metastatic Invasive Breast Cancer (NCT01302821) | H. Lee Moffitt Cancer Center and Research Institute | 2013-01-01 |
| IDENTIFICATION OF SENTINEL NODE(S) IN BREAST CANCER (NCT01790399) | Centre Oscar Lambret | 2013-01-01 |
| Kinetics of Troponin and BNP in Breast Cancer Chemotherapy With Adriamycin and Trastuzumab (NCT01771549) | Mayo Clinic | 2013-01-01 |
| Ultra High Field MRI and MRS Techniques in Diagnosing Breast Cancer (NCT01938651) | Vanderbilt-Ingram Cancer Center | 2013-01-01 |
| A Randomized Trial of Chemotherapy in Surgical Patients With Infiltrating Ductal Carcinoma of Breast (NCT02897700) | Shanghai Jiao Tong University School of Medicine | 2013-01-01 |
| Evaluation of Two Boost Radiation Schedules in Post Lumpectomy Early Stage Carcinoma Breast (NCT02142907) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2013-01-01 |
| Autologous Natural Killer T Cells Infusion for the Treatment of Cancer (NCT01801852) | Chinese PLA General Hospital | 2013-01-01 |
| MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum (NCT01719562) | Wake Forest University Health Sciences | 2013-01-01 |
| Effect of Interval Cancer and Screening Process on Survival and Disease-free Period in Breast Cancer (NCT03165006) | Parc de Salut Mar | 2013-01-01 |
| Study of Pyrotinib in Patients With Human Epidermalgrowth Factor Receptor 2 (HER2) Positive Advanced Breast Cancer (NCT01937689) | Jiangsu HengRui Medicine Co., Ltd. | 2013-01-01 |
| Web-based Screening and Tailored Support (NCT01834521) | University Medical Center Groningen | 2013-01-01 |
| Supervised Aerobic Training During or After Chemotherapy for Operable Breast Cancer (NCT01943695) | Memorial Sloan Kettering Cancer Center | 2013-01-01 |
| Feasibility and Impact of Group Interventions on Breast Cancer Patients Well-being (NCT02569294) | University of Liege | 2013-01-01 |